Amgen Inc.
VARIANTS OF TISSUE INHIBITOR OF METALLOPROTEINASE TYPE THREE (TIMP-3), COMPOSITIONS AND METHODS
Last updated:
Abstract:
There are disclosed TIMP-3 muteins, variants and derivatives, nucleic acids encoding them, and methods of making and using them.
Status:
Application
Type:
Utility
Filling date:
1 Oct 2021
Issue date:
24 Mar 2022